China's Strong Economic Growth and Healthcare Investments Generate Success for CPhI

AsiaNet 53928

AMSTERDAM, Aug. 13, 2013 /PRN=KYODO JBN/ --

    - China's 'Five Year Plan' underway as attendance at 2013 show rockets

    CPhI and UBM Live today announced that this year's recent CPhI China 2013,

which took place on 25th-27th June at the Shanghai New International Expo

Centre, was the most successful exhibition to date.

    (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

    Attendance rates far exceeded expectation and CPhI and P-MEC China,

alongside co-located events BioPh, ICSE, InnoPack, hosted a record breaking

more than 2,400 companies, both local and international, and attracted more

than 30,000 visitors from 133 countries throughout the world.

    The 13th consecutive event was the foremost meeting point and networking

opportunity for senior Chinese pharma professionals and international

pharmaceutical suppliers and buyers.

    In response to the implementation of China's 'five year plan', CPhI China

2013 saw a strong focus on research and development with LABWorld, BioPharma

and ICSE all contained in one hall, mirroring China's continued commitment to

this area and reflecting its exemplary position in the pharmaceutical world.

    R&D investments in China have been at a high throughout 2013- it has been

estimated that growth in investment within this area matches that of the USA.

The [12th] 'Five-Year Plan', implemented by the Chinese government targets

pharmaceutical R&D as a key initiative, with financial and beneficial

incentives being offered in order to encourage R&D activities within the

country. These include exemption from import customs duty on R&D equipment and

a reduced income tax rate. In light of this, the R&D focus at CPhI China 2013

provided an informative update on the efforts being made by the government in

facilitating innovation within the country.

    On-site at CPhI China 2013, the "China and World" Medical Forum proved

highly insightful and valuable for attendees. Having received substantial

support from a vibrant speaker team of government and leading pharmaceutical

companies, the forum showcased hot topic seminars and conferences. These

covered the latest policies and regulations within the pharmaceutical industry

and the practical applications of new technology. Furthermore, the Buyer

Sourcing Event, with more than 60 buyers, 280 sessions and over 90% successful

match rate, has provided a catalyst for increased business connections in the

region.

    Chris Kilbee, CPhI Pharma Group Director at UBM Live commented, "The

Chinese pharmaceutical industry is now the third largest in the world and is

ever growing -- it is predicted to expand at the annual rate of 12% from 2013

to 2020. Having witnessed a shift in focus to R&D by China, CPhI China 2013 was

designed to reflect these widespread changes. The event was undoubtedly a

success for both UBM Live, CCMHPIE and our attendees and, consequently, over

40% of exhibitors present have already registered for next year. This result

shows that CPhI China is now at the centre of pharmaceutical business

connections within the region."

    CPhI 2014 will return alongside co-located events ICSE, BioPh, P-MEC,

InnoPack and Labworld, on 26th -28th June, 2014 at the Shanghai New

International Expo Centre. The exhibition will increase its scale and,

reiterating the importance of R&D in China as CPhI China 2014 will focus on

biopharmaceutical R&D with 'BioPh China' and 'ICSE China' making up an integral

part of the exhibition. A further main focus for next year will be natural

extracts in which exhibiting companies will occupy more than one hall.

    The UBM Live annual schedule of Pharmaceutical events also includes CPhI

Worldwide, ICSE, P-MEC Europe and InnoPack (22-24 October, 2013 at Messe

Frankfurt, Germany); CPhI and P-MEC India (03-05 December, 2013 at the Bombay

Exhibition Centre in Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan

(9-11 April, 2014 in Tokyo); CPhI Russia and IPhEB (16-17 April, 2014 in St

Petersburg, Russia); CPhI, P-MEC and Innopack South East Asia (20-22 May, 2014

in Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, Turkey)

    http://www.cphi-china.com

    The UBM Live annual schedule of Pharmaceutical events also includes CPhI,

ICSE and BioPh South America (06-08 August, 2013 at the Expo Center Norte in

Sao Paulo, Brazil); CPhI Worldwide, ICSE, P-MEC Europe and InnoPack (22-24

October, 2012 at Messe Frankfurt, Germany; CPhI and P-MEC India (03-05

December, 2013 at the Bombay Exhibition Centre in Mumbai); CPhI, ICSE, P-MEC,

BioPh and Pharmatec Japan (9-11 April, 2014 in Tokyo); CPhI Russia and IPhEB

(16-17 April, 2014); CPhI, P-MEC and Innopack SE Asia (20-22 May, 2014 in

Jakarta, Indonesia); CPhI, P-MEC, ISCE, InnoPack Istanbul (4-6 June 1014 in

Istanbul) CPhI, P-MEC, ICSE, InnoPack and BioPh China (26-28 June 2014 in

Shaghai).

    About CPhI

    CPhI drives growth and innovation at every step of the global

pharmaceutical supply chain from drug discovery to finished dosage. Through

exhibitions, conferences and online communities, CPhI brings together more than

100,000 pharmaceutical professionals each year to network, identify business

opportunities and expand the global market. CPhI hosts events in Europe, China,

India, Japan, Southeast Asia, Russia and South America co-located with ICSE for

contract services, P-MEC for machinery, equipment & technology, InnoPack for

pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer

& supplier directory at CPhI-Online.com and hosts a global community with news

and analysis at PharmaEvolution.com.

    For more information visit: http://www.cphi.com

    About UBM Live

    UBM Live connects people and creates opportunities for companies across

five continents to develop new business, meet customers, launch new products,

promote their brands, and expand their market. Through premier brands such as

TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete

Show, and many others, UBM Live exhibitions, conferences, awards programs,

publications, Websites, and training and certification programs are an integral

part of the marketing plans of companies across more than 20 industry sectors.

    For media enquiries, please contact:

    Alex Heeley or Tristan Jervis, De Facto Communications,

    T: +44-(0)207-203-6745 / 6740,

    E: a.heeley@defacto.com / t.jervis@defacto.com

    SOURCE: UBM Live